Recent advances in the development of sphingosine kinase inhibitors
Abstract Sphingosine kinase (SK) 1 and 2 are lipid kinases that catalyse the formation of
sphingosine 1-phosphate (S1P), a potent signalling molecule with a wide array of cellular …
sphingosine 1-phosphate (S1P), a potent signalling molecule with a wide array of cellular …
The tumorigenic effect of sphingosine kinase 1 and its potential therapeutic target
X Wang, Y Sun, X Peng, SMAS Naqvi… - Cancer …, 2020 - journals.sagepub.com
Sphingosine kinase 1 (SPHK1) regulates cell proliferation and survival by converting
sphingosine to the signaling mediator sphingosine 1-phosphate (S1P). SPHK1 is widely …
sphingosine to the signaling mediator sphingosine 1-phosphate (S1P). SPHK1 is widely …
SphK1 inhibitor II (SKI-II) inhibits acute myelogenous leukemia cell growth in vitro and in vivo
L Yang, W Weng, ZX Sun, XJ Fu, J Ma… - … and biophysical research …, 2015 - Elsevier
Previous studies have identified sphingosine kinase 1 (SphK1) as a potential drug target for
treatment of acute myeloid leukemia (AML). In the current study, we investigated the …
treatment of acute myeloid leukemia (AML). In the current study, we investigated the …
Sphingosine kinase 1 contributes to doxorubicin resistance and glycolysis in osteosarcoma
X Ren, C Su - Molecular Medicine Reports, 2020 - spandidos-publications.com
Osteosarcoma (OS) is one of the most common and aggressive malignancies in children
and adolescents worldwide. Sphingosine kinase 1 (SphK1) has recently been reported to …
and adolescents worldwide. Sphingosine kinase 1 (SphK1) has recently been reported to …
Investigating the regulatory role of ORMDL3 in airway barrier dysfunction using in vivo and in vitro models
R Yang, M Tan, J Xu, X Zhao - … journal of molecular …, 2019 - spandidos-publications.com
The airway epithelium (AE) is the main protective barrier between the host and external
environmental factors causing asthma. Allergens or pathogens induce AE dysfunction …
environmental factors causing asthma. Allergens or pathogens induce AE dysfunction …
Emerging role of sphingosine-1-phosphate signaling in head and neck squamous cell carcinoma
Head and neck squamous cell carcinoma (HNSCC) is the sixth most frequent cancer type,
with an annual incidence of approximately half a million people worldwide. It has a high …
with an annual incidence of approximately half a million people worldwide. It has a high …
[HTML][HTML] Sphingosine kinase 1 is overexpressed and promotes adrenocortical carcinoma progression
Y Xu, B Dong, J Huang, W Kong, W Xue, Y Zhu… - Oncotarget, 2016 - ncbi.nlm.nih.gov
Adrenocortical carcinoma (ACC) is a rare endocrine tumor with a very poor prognosis.
Sphingosine kinase 1 (SphK1), an oncogenic kinase, has previously been found to be …
Sphingosine kinase 1 (SphK1), an oncogenic kinase, has previously been found to be …
[HTML][HTML] Epidermal growth factor receptor variant III in head and neck squamous cell carcinoma is not relevant for targeted therapy and irradiation
DT Koch, A Pickhard, L Gebel, AMS Buchberger… - Oncotarget, 2017 - ncbi.nlm.nih.gov
Background The epidermal growth factor receptor (EGFR) is an important regulator of cell
growth and survival, and is highly variable in tumor cells. The most prevalent variation of the …
growth and survival, and is highly variable in tumor cells. The most prevalent variation of the …
[HTML][HTML] SphK1-targeted miR-6784 inhibits functions of skin squamous cell carcinoma cells
ZH Gong, J Ji, J Yao, JF Ji, Y Jiang, G Gao… - Aging (Albany NY …, 2021 - ncbi.nlm.nih.gov
Abstract Sphingosine kinase 1 (SphK1) is overexpressed in skin squamous cell carcinoma
(SCC). It has emerged as a novel therapeutic oncotarget. The current study identified a …
(SCC). It has emerged as a novel therapeutic oncotarget. The current study identified a …
Interaktion zwischen Kopf-Hals-Tumoren und mesenchymalen Fettgewebsstammzellen
DD Utz - 2023 - mediatum.ub.tum.de
Es konnte gezeigt werden, dass Kopf-Hals-Plattenepithelkarzinomzellen (HNSCC) zu
gesteigerter Migration von mesenchymalen Fettgewebsstammzellen (ASC) in vitro führen …
gesteigerter Migration von mesenchymalen Fettgewebsstammzellen (ASC) in vitro führen …